JIP
RIGL icon

Jaffetilchin Investment Partners’s Rigel Pharmaceuticals RIGL Stock Holding History

Jaffetilchin Investment Partners’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,293
Closed -$325K – 399
2021
Q2 		$325K Buy
+9,293
New +$351K 0.02% 313
2021
Q1 		– Sell
-9,293
Closed -$325K – 377
2020
Q4 		$325K Buy
9,293
+3,791
+69% +$110K 0.05% 216
2020
Q3 		$132K Buy
5,502
+3,098
+129% +$76.1K 0.02% 217
2020
Q2 		$44K Buy
+2,404
New +$43.2K 0.01% 200
2019
Q3 		– Sell
-4,131
Closed -$108K – 259
2019
Q2 		$108K Buy
+4,131
New +$93.2K 0.03% 253

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jaffetilchin Investment Partners's RIGL Position: Q3 2021 in Review

Jaffetilchin Investment Partners sold out of Rigel Pharmaceuticals (RIGL) in Q3 2021, closing a stake of 9,293 shares — an estimated $325K sold.

Jaffetilchin Investment Partners first reported a position in RIGL in Q2 2019 and held it in 5 quarters. The position peaked at $325K in Q2 2021. 163 funds tracked by Wall St. Rank hold RIGL as of Q3 2021.

  • Jaffetilchin Investment Partners reported no remaining Rigel Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 9,293 Rigel Pharmaceuticals shares in Q3 2021, an estimated $325K.
  • Jaffetilchin Investment Partners first reported a position in Rigel Pharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Jaffetilchin Investment Partners's Rigel Pharmaceuticals position peaked at $325K in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2021.

Based on Jaffetilchin Investment Partners's 13F filing for Q3 2021, filed 25 Oct 2021.